Basic Information
Basic information for LINC00662-214-39aa
Peptide Name LINC00662-214-39aa
Genome Position chr19:27715500-27715616[-]
Species Human
Peptide Sequence MCIHLTVQNFFFDSTGWKLCFCKINEGTFLSPLKPIVKN
Peptide Length 39
Unique No (LINC00662-225-39aa)
Grand Average of Hydropathicity 0.3103
Relative Molecular Mass 5206.07
Experimental Evidences 3:MS,m6A,ribo
lncRNA ID/Name ENSG00000261824;LINC00662
Transcript ID/Name ENST00000654098;LINC00662-214
Transcript Length 3832
Coding Ability 0.429
DNA Sequence Corresponding to Peptide ATGTGCATTCATCTCACAGTGCAAAACTTTTTCTTTGATTCAACAGGTTGGAAACTCTGTTTTTGTAAAATTAATGAAGGCACATTTCTGAGCCCTTTGAAACCTATAGTGAAAAAC
Experimental Evidences
   Mass Spectrometry
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :